Results 161 to 170 of about 4,944 (197)
Some of the next articles are maybe not open access.
Selectivity information on desogestrel
American Journal of Obstetrics and Gynecology, 1993Improvement in oral contraceptive formulations was originally achieved through dose reduction of the estrogen and progestogen components. Recently, further improvement was achieved by increasing the selectivity of contraceptive progestins. The ratio between the affinity for the progesterone receptor and the affinity for the androgen receptor is an ...
openaire +2 more sources
Serum levels of 3-keto-desogestrel after oral administration of desogestrel and 3-keto-desogestrel
Contraception, 1986In a cross-over study with orally administered desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) and 3-keto-desogestrel (0.150 mg) plus ethinyloestradiol (0.030 mg) in ten women under steady-state conditions, the serum levels of 3-keto-desogestrel were monitored by radioimmunoassay.
H G, Hasenack, A M, Bosch, K, Käär
openaire +2 more sources
Contraception, 1987
The plasma concentrations of 3-keto-desogestrel have been measured by radioimmunoassay in a crossover study in nine healthy female volunteers given oral desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms) and intravenous (i.v.) 3-keto-desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms).
D J, Back +3 more
openaire +2 more sources
The plasma concentrations of 3-keto-desogestrel have been measured by radioimmunoassay in a crossover study in nine healthy female volunteers given oral desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms) and intravenous (i.v.) 3-keto-desogestrel (150 micrograms) and ethinyloestradiol (30 micrograms).
D J, Back +3 more
openaire +2 more sources